Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-152-2 | CAS number: 78-87-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.4900 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes
Test material
- Reference substance name:
- 1,2-dichloropropane
- EC Number:
- 201-152-2
- EC Name:
- 1,2-dichloropropane
- Cas Number:
- 78-87-5
- Molecular formula:
- C3H6Cl2
- IUPAC Name:
- 1,2-dichloropropane
- Details on test material:
- Name: 1,2-dichloropropane
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Duration of treatment / exposure:
- GD 6 - 15 inclusive
- Frequency of treatment:
- daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 (corn oil), 10, 30 or 125 mg/kg bwt/d
Basis:
- Control animals:
- yes, concurrent vehicle
Results and discussion
Results: maternal animals
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw (total dose)
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
Effect levels (fetuses)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 125 mg/kg bw (total dose)
- Basis for effect level:
- other: teratogenicity
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw (total dose)
- Basis for effect level:
- other: fetotoxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Mean analysed concentrations of PDC were 5.0 (0.0), 15.0 (0.0) and 62.5 (2.0) mg/ml (SD in brackets).
Maternal observations
Clinical signs (ie decreased movement and muscle tone, increased lacrimation, decreased extensor reflex and increased salivation) were present in high dose animals on GD 6 and to a lesser extent on GD 7. Despite the transitory nature of these changes, they appeared indicative of an adverse effect in dams from the high dose group. No clinical effects were seen on other days in the high dose group, or on any day in the mid- or low dose animals.
Body weights were slightly (3-5%) but significantly lower in high dose dams throughout the study. Body weight gain was decreased significantly in high dose dams on GD 6-9, and although comparable to control during the mid- and latter stages of pregnancy the overall weight increase in the 125 mg/kg bwt/day group was approx. 30% lower than controls on GD 6-16 (that is, during the dosing period). Food consumption was reduced approx. 25% on GD 6-9, and water consumption increased by the same amount on GD 9-12 and 12-15.
There were no significant effects on absolute or relative organ weights, or on uterine weights or pregnancy parameters (including number of litters, corpora lutea per dam, implantations per dam, live fetuses per litter, resorptions, fetal bwt, etc).
Fetal observations
A low incidence of malformations was present in all groups, with no qualitative or quantitative increase in litters from treated dams. Overall there was no indication that PDC was a teratogen.
Fetal variations were present in both control and treated groups. The only treatment-related effect was a significant increase in the incidence of delayed ossification of the bones of the skull among fetuses from the high dose group. Interestingly, the occurrence of this observation was most common in high dose litters containing 16 or more pups. All other parameters were comparable to the controls.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the study, mild fetotoxicity (as evidenced by decreased ossification of the bones of the skull) was noted in litters from dams given 125 mg/kg bwt PDC/day. This effect was most common in the larger litters, and was co-incident with significant reductions in body
weight gain and food consumption. It is concluded that the NOAEL for both maternal and fetal toxicity was 30 mg/kg bwt/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.